David Zaccardelli, President and CEO at Verona Pharma plc (VRNA), sold 224,216 shares at $5.01 ($1.1M) on 2024-11-29, disclosed to the SEC on 2024-12-02.
Scheduled sale ($1.1M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.00 | 23,240 | $116K | 10.3% |
| 2 | $5.01 | 98,888 | $495K | 44.1% |
| 3 | $5.01 | 98,888 | $495K | 44.1% |
| 4 | $5.00 | 3,200 | $16K | 1.4% |
| Total | $5.01 avg | 224,216 | $1.1M | 100% |
| Filing → |
| VRNA | SELL | 2025-05-29 | $7.1M | — | Filing → |
| VRNA | SELL | 2025-05-05 | $7.0M | — | Filing → |
| VRNA | SELL | 2025-05-01 | $1.6M | — | Filing → |